Karen Boezi is the Chief Operating Officer of Thirona Biosciences. She has been involved in building, leading and investing in biopharmaceutical companies for more than 30 years. Karen was the CEO of Redwood Bioscience, leading the company through its successful sale to Catalent, which she closed in less than four years after joining the founding team. Redwood continues to be a pioneer in developing ADCs. Based on research from the lab of Nobel Laureate, Carolyn Bertozzi, it now has a pipeline of 10 ADCs, four already out-licensed. Prior to joining Redwood, Karen was a founding Partner of Thomas, McNerney & Partners which she launched with a colleague from Warburg, Pincus, where she was with the seed stage team, and a partner from Coral Ventures, where she was a General Partner. During her venture career, she invested in 15 companies that went public and/or were acquired. She launched three companies with scientific founders. Karen began her career at Alex. Brown & Sons. More recently, Karen has been an angel investor and advisor to academic scientists founding biopharmaceutical companies. She graduated Phi Beta Kappa with a B.S. in Economics from the Wharton School at the University of Pennsylvania.